About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Chordia Therapeutics Inc., The Current Fiscal Year's Net Income to Widen

Fri Oct 11, 2024 11:30 am JST Earnings

190A Chordia Therapeutics Inc. 【J-GAAP】

Earnings Report

Chordia Therapeutics Inc. <190A> [TSE-G] announced its financial results at noon (11:30) on October 11th. The net income/loss (non-consolidated) for the fiscal year ending August 2024 turned into a loss of 1.82 billion yen (compared to a profit of 223 million yen in the previous period). For the fiscal year ending August 2025, the loss is expected to be loss of 2.38 billion yen.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
YoY 0.0% 0.0% 0.0% 0.0%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 Guidance -2,273 -2,278 -2,280 -33.8 0 Jun 14, 2024 J-GAAP
Aug, 2024 Results 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Revision Rate +20.8% +19.9% +19.9% +7.9%

Current Period Guidance

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Aug, 2025 Guidance -2,434 -2,378 -2,380 -34.9 0 Oct 11, 2024 J-GAAP
YoY -35.1% -30.4% -30.3% -12.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Mar - May, 2024 0 -371 -374 -375 -6.7 -Inf Jul 16, 2024 J-GAAP
Jun - Aug, 2024 0 -621 -649 -650 -11.1 -Inf Oct 11, 2024 J-GAAP
YoY

Related Articles